About: Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1985

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1985 (uk) im März 1985 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 1985 (ast) scientific article published on 01 March 1985 (en)
publication date	wds:Q70067576-D29B910F-17E7-4320-8E80-E3F7FB748B85
publication date	1985-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q70067576-DF44AAF3-4634-406D-9F0A-46570312EF23
language of work or name	English
author name string	wds:Q70067576-1F8F0C00-29C5-4E9A-8C2B-CAC2BFAE5AF1 wds:Q70067576-6D9C1761-A539-4674-A993-5B7627D76E2C wds:Q70067576-AC7210FE-B080-4BCF-B326-75C81C0A999B
author name string	B von Schoultz B G Johansson U B Ottosson
rdfs:label	Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone (en) Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone (nl)
skos:prefLabel	Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone (en) Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone (nl)
name	Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone (en) Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone (nl)
title	wds:Q70067576-5057D698-383E-4D00-B2A1-F445C20032A0
title	Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone (en)
page(s)	wds:Q70067576-82FBCCB8-472F-4DF7-B292-F328130845D4
page(s)	746-750
instance of	wds:Q70067576-11710984-7E47-41BF-BC50-61C806161060
instance of	scholarly article
main subject	wds:Q70067576-AEB2996A-1B52-497E-98C0-C47EB4A6BF6A
main subject	estrogen
PubMed ID	wds:Q70067576-12E5F682-D084-4D17-A613-2D375E59C9CE
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3976784
PubMed ID	3976784
published in	wds:Q70067576-E1CA7332-EC00-4DB6-9519-A181ED330027
published in	American Journal of Obstetrics and Gynecology
issue	wds:Q70067576-F068C031-B3AA-481B-942D-BBAF6ECA4B62
volume	wds:Q70067576-67B83E87-D2AB-47F7-9D65-60372517CF9C
issue	6
volume	151
DOI	wds:Q70067576-73ECB7ED-639A-4776-B75B-CB48B5D0727D
DOI	http://dx.doi.org/10.1016/0002-9378(85)90509-5
DOI	10.1016/0002-9378(85)90509-5
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70067576
is cites work of	The role of hormones and aromatase inhibitors on breast tumor growth and general health in a postmenopausal mouse model Epidemiological overview of oestrogen replacement and cardiovascular disease Metabolic effects of oral contraceptives Oral micronized progesterone The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone†Supported in part by a grant from Besins-Iscovesco, Paris, France.†Presented in part at the 35th Annual Mee Factors associated with withdrawal bleeding after administration of oral micronized progesterone in women with secondary amenorrhea Endometrial safety of continuous combined hormone replacement therapy with 17beta-oestradiol (1 or 2 mg) and dydrogesterone LHRH agonists and the prevention of breast and ovarian cancer Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women Estrogen replacement therapy and protection from acute myocardial infarction Continuous estrogen/progestin therapy in menopause 12 Cost-effectiveness of hormone replacement therapy after the menopause Estrogen therapy during menopause. Practical treatment recommendations The optimal dose of oral norethindrone acetate for addition to transdermal estradiol: a multicenter study. Lipids and cardiovascular disease: Do the findings and therapy apply equally to men and women? Acute effects of estradiol and progesterone on insulin, lipids and lipoproteins in postmenopausal women: a pilot study. The adverse effects of hormonal therapy. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives Management of dysfunctional uterine bleeding. Double-blind controlled trial of progesterone vaginal cream treatment for cyclical mastodynia in women with benign breast disease Serum lipids and lipoproteins in continuous or cyclic medroxyprogesterone acetate treatment in postmenopausal women treated with conjugated estrogens Estrogen replacement therapy: indications, contraindications, and agent selection Cardiovascular benefits of estrogen replacement therapy Cardiovascular risk factors during sequentially combined 17 beta oestradiol and dydrogesterone (Femoston); results from a one-year study in postmenopausal women. Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial Hormone replacement therapy, hormone levels, and lipoprotein cholesterol concentrations in elderly women Luteal phase support Past and present preferred prescribing practices of hormone replacement therapy among Los Angeles gynecologists: possible implications for public health Transdermal estroprogestins versus transdermal estrogen plus oral dihydrogesterone replacement in menopause Hormone replacement therapy in the aged. A state of the art review Endocrinology in aging 8 Effects of sex steroids on serum lipids and lipoproteins Postmenopausal hormone replacement: are two hormones better than one? Induction and Maintenance of Amenorrhea in Transmasculine and Nonbinary Adolescents. Differential Effects of Estradiol and Progesterone on Cardiovascular Risk Factors in Postmenopausal Women. Natural Micronized Progesterone Sustained Release (SR) and Luteal Phase: Role Redefined!! Absorption and metabolism of oral progesterone when administered twice daily**Supported by a grant from Laboratoires Besins Iscovesco, Paris, France Introduction to steroids in the menopause Serum lipids in postmenopausal or perimenopausal women using estrogen alone, estrogen with levonorgestrel, or estrogen with norethisterone, compared with nonusers: results from a cross-sectional study in two Norwegian counties 1985-1988 Effects of postmenopausal hormone replacement and alpha-tocopherol on the lipid profiles and antioxidant status A rationale for the current management of post-menopausal osteoporosis. Lipid effects of endocrine medications Miscellaneous medications for the management of atherosclerosis: mayhem or miracle? That oestrogen replacement for osteoporosis prevention should no longer be a bone of contention Exploring the role of progestins and phytoestrogens in menopause. Differences in erythrocyte membrane cholesterol to phospholipids ratio in postmenopausal women with and without hormone replacement
is cites work of	wds:Q33544590-B579408E-6ADE-469A-A8D7-130BE1738545 wds:Q37070552-11862B16-50F8-4868-8CFC-DF12A13E0454 wds:Q59485376-25D02684-5865-4799-9B49-DF1A831AE690 wds:Q68305001-0D536F2F-73A3-42F8-9E43-0C8BB742A819 wds:Q71510392-E006078A-67F9-4C50-8602-90607E80290E wds:Q40877167-91225CD7-D47E-4A95-BCE8-A6E057BCDE1A wds:Q38746808-5B3504ED-C185-47F2-ACA4-8890277B3C0E wds:Q37070492-C9B398D4-6A71-419F-8281-694E2A2D9DE2 wds:Q40864441-B42EA6B0-0459-4BFE-BF56-BD6FE2AAA2BD wds:Q46496588-1704E1ED-6351-4A97-8C39-0E057B4A610F

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software